Opinion on the re-evaluation of ascorbyl palmitate (e 304i) as a food additive in foods for infants below 16 weeks of age and the follow-up of its re-evaluation as a food additive for uses in foods for all population groups - Université de Lille Accéder directement au contenu
Article Dans Une Revue EFSA Journal Année : 2020

Opinion on the re-evaluation of ascorbyl palmitate (e 304i) as a food additive in foods for infants below 16 weeks of age and the follow-up of its re-evaluation as a food additive for uses in foods for all population groups

Maged Younes
  • Fonction : Auteur
Gabriele Aquilina
  • Fonction : Auteur
Laurence Castle
  • Fonction : Auteur
Karl-Heinz Engel
  • Fonction : Auteur
Paul Fowler
  • Fonction : Auteur
Maria Jose Frutos Fernandez
  • Fonction : Auteur
Peter Furst
  • Fonction : Auteur
Rainer Gurtler
  • Fonction : Auteur
Trine Husoy
  • Fonction : Auteur
Melania Manco
  • Fonction : Auteur
Wim Mennes
  • Fonction : Auteur
Peter Moldeus
  • Fonction : Auteur
Sabina Passamonti
  • Fonction : Auteur
Romina Shah
  • Fonction : Auteur
Ine Waalkens-Berendsen
  • Fonction : Auteur
Detlef Wolfle
  • Fonction : Auteur
Matthew Wright
  • Fonction : Auteur
Birgit Dusemund
  • Fonction : Auteur
Alicja Mortensen
  • Fonction : Auteur
Stefania Barmaz
  • Fonction : Auteur
Camilla Smeraldi
  • Fonction : Auteur
Alexandra Tard
  • Fonction : Auteur
Giorgia Vianello
  • Fonction : Auteur
Ana Maria Rincon
  • Fonction : Auteur
Ursula Gundert-Remy
  • Fonction : Auteur

Résumé

Ascorbyl palmitate (E 304(i)) was re-evaluated in 2015 by the former EFSA Panel on Food Additives and Nutrient sources added to Food (ANS). As a follow-up to this assessment, the Panel on Food Additives and Flavourings (FAF) was requested to assess the safety of ascorbyl palmitate (E 304(i)) for its uses as food additive in food for infants below 16 weeks of age belonging to food categories 13.1.1 (Infant formulae) and 13.1.5.1 (Dietary foods for infants for special medical purposes and special formulae for infants) and as carry over in line with Annex III, Part 5 Section B to Regulation (EC) No 1333/2008. In addition, the FAF Panel was requested to address the issues already identified during the re-evaluation of the food additive when used in food for the general population. The process involved the publication of a call for data to allow the interested business operators to provide the requested information to complete the risk assessment. On the basis of the data submitted by interested business operators and the considerations from the Panel, a revision of the existing EU specifications for ascorbyl palmitate (E 304 (i)) has been recommended. Based on in vitro data, the FAF Panel assumed that ascorbyl palmitate fully hydrolyses pre-systemically to ascorbic acid and palmitate. The Panel concluded that the intake of both metabolites, at the MPLs for ascorbyl palmitate as a food additive in infant formula belonging to FC 13.1.1 or in food for special medical purposes belonging to FC 13.1.5.1, does not raise health concerns.
Fichier principal
Vignette du fichier
EFSA Journal - 2020 - - Opinion on the re‐evaluation of ascorbyl palmitate E 304i as a food additive in foods for.pdf (3.56 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04388032 , version 1 (11-01-2024)

Licence

Identifiants

Citer

Maged Younes, Gabriele Aquilina, Laurence Castle, Karl-Heinz Engel, Paul Fowler, et al.. Opinion on the re-evaluation of ascorbyl palmitate (e 304i) as a food additive in foods for infants below 16 weeks of age and the follow-up of its re-evaluation as a food additive for uses in foods for all population groups. EFSA Journal, 2020, EFSA Journal, 18, pp.e06153. ⟨10.2903/j.efsa.2020.6153⟩. ⟨hal-04388032⟩

Collections

RIIP UNIV-LILLE
1 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More